Functional genomics of the Down syndrome.
Down syndrome, as a phenotypic result of trisomy 21, is a complex condition with a set of over 30 phenotypic features, which manifest themselves with varying frequencies among affected individuals. The importance for molecular medicine of understanding the molecular mechanisms underlying Down syndrome becomes fully appreciated when a striking feature of Down syndrome is taken into account: that the overdose of otherwise perfectly normal genes causes disorders of human health, indistinguishable from major public health problems of the general population, such as mandatory early onset Alzheimer s degeneration, increased risk of leukemia, and protection from cancer of solid tissues. The DNA sequence of human chromosome 21 is, at the moment, the most complete piece of DNA sequence known in the whole of human genome. The challenge for the future is an integrated, multidisciplinary approach to the molecular biology of chromosome 21 genes, in conjunction with the research into the variation in their genotype, expression, and function in the normal population, in Down syndrome individuals with well-characterized phenotypic traits, and in euploid patients suffering from diseases associated with phenotypic components of Down syndrome: mental retardation, developmental defects, hematological and solid tissue malignancies, and Alzheimer s disease.
Nizetić
D
D
Centre for Applied Molecular Biology, School of Pharmacy, University of London, 29/39 Brunswick Square, London WC1N 1AX, UK. dean.nizetic@ams1.ulsop.ac.uk
D000544:Alzheimer Disease / Q000453:epidemiology / Q000235:genetics / Q000473:pathology; D016229:Amyloid beta-Peptides / Q000502:physiology; D001921:Brain / Q000473:pathology; D002891:Chromosomes, Human, Pair 21 / Q000235:genetics*; D015897:Comorbidity; D004314:Down Syndrome / Q000453:epidemiology / Q000235:genetics* / Q000473:pathology; D006801:Humans; D066298:In Vitro Techniques; D007360:Intelligence; D007938:Leukemia / Q000453:epidemiology / Q000235:genetics; D019891:Leukopoiesis / Q000235:genetics
D016229:Amyloid beta-Peptides